Jaime M. Pita

发表

Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and “swarm intelligence”

V. Detours, J. Dumont, C. Maenhaut, 2013, Cancer and Metastasis Reviews.

Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas

J. M. Pita, A. Banito, V. Leite, 2009, British Journal of Cancer.

Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas.

J. M. Pita, I. Figueiredo, V. Leite, 2014, The Journal of clinical endocrinology and metabolism.

miRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancers

V. Detours, J. Dumont, C. Maenhaut, 2016, Oncotarget.

MiRNA Expression May Account for Chronic but Not for Acute Regulation of mRNA Expression in Human Thyroid Tumor Models

J. Dumont, C. Maenhaut, J. M. Pita, 2014, PloS one.

JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21

R. Davis, K. Coulonval, E. Raspé, 2017, Oncogene.

CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib

Isabelle Salmon, Sylvain Brohée, Christos Sotiriou, 2017, EMBO molecular medicine.

Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy

J. M. Pita, C. Jungels, G. Costante, 2022, Current opinion in oncology.

CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas

J. Dumont, L. Marlow, K. Coulonval, 2023, bioRxiv.

Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

K. Coulonval, E. Raspé, J. M. Pita, 2021, Cell cycle.